KAPA vs GILD: Which Stock is Better?
Side-by-side comparison of Kairos Pharma Ltd and Gilead Sciences Inc in 2026
KAPA
Kairos Pharma Ltd
$0.61
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | KAPA | GILD | Winner |
|---|---|---|---|
| Market Cap | $13.10M | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze KAPA
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KAPA or GILD a better investment?
Comparing KAPA and GILD: Kairos Pharma Ltd has a market cap of $13.10M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KAPA and GILD?
KAPA (Kairos Pharma Ltd) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KAPA or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KAPA or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for KAPA.
Which company is more profitable: KAPA or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for KAPA.
Which is the larger company: KAPA or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $13.10M for KAPA.
Should I buy KAPA or GILD in 2026?
Both KAPA and GILD have investment merit. KAPA trades at $0.61 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KAPA and GILD stock?
Key differences: Market Cap ($13.10M vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).